Today news
About the same in other media
GoodRx stock plummets 18% on Q3 revenue miss & weak guidance
Reading now: 158
GoodRx Holdings (GDRX) shares closed with more than an 18% loss on Thursday after the company reported its Q3 results.
Revenue for the quarter came in at $180 million (down 4% year-over-year), missing the consensus estimate of $188.52M, primarily due to a $10M contract termination payment to a client in Q3, which was recognized as a reduction of revenue, partially offset by organic growth in prescription transactions revenue.
Q3 EPS was $0.06, in line with the Street estimates.
For Q4/23, the company expects revenue to be in the range of $188-$194M, compared to the consensus of $192.7M.
For the full year, the company sees revenue at $742-$748M, compared to the consensus estimate of $754.9M.
Read more on investing.comAbout this in other media
After-hours movers: Cisco, Palo Alto Networks sink on weaker guidance investing.com /1 year ago
Stock Market Today: Dow in 2nd weekly win as tech stocks fuel major rebound investing.com /1 year ago
Stock market update: Sugar stocks down as market rises economictimes.indiatimes.com /1 year ago
Show more
The website fvbb.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
